Instituto de Biomedicina de Sevilla
In research, Instituto de Biomedicina de Sevilla stands highest in Life Sciences (#1,758 of 7,800 worldwide), Medicine (#2,408 of 10,443 worldwide) and Health Sciences (#2,952 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #3,983 of 28,054 · #6,610 all time
- Rank in Spain
- #96 of 658
- Research works
- 1.3k ▲ 31% vs 2013–17
- Citations
- 29k 22.8 per fractional work
- Top-10% rate
- 24.8% record average 16.5%
- Open access
- 64% world 28%
What is Instituto de Biomedicina de Sevilla known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #1,758 of 7,800 | 26.0% | 124 | #2865 | |
| MedicineField | #2,408 of 10,443 | 22.6% | 242 | #3494 | |
| Health SciencesDomain | #2,952 of 11,982 | 23.1% | 256 | #4461 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,271 of 3,579 | 23.8% | 73 | #3553 |
Each strip is that field’s whole ranked pool, with the notch where Instituto de Biomedicina de Sevilla sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#2,865 #1,758
- Medicine#3,494 #2,408
- Health Sciences#4,461 #2,952
- Biochemistry, Genetics and Molecular Biology#3,553 #2,271
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.6×. Every wedge is a field page.
- Immunology and Microbiology 4.6×
- Neuroscience 3.4×
- Biochemistry, Genetics and Molecular Biology 3.2×
- Medicine 3.0×
- Nursing 1.7×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Psychology 0.9×
- Health Professions 0.8×
- Dentistry 0.7×
- Decision Sciences 0.4×
- Chemistry 0.4×
- Agricultural and Biological Sciences 0.3×
- Veterinary 0.3×
- Environmental Science 0.2×
- Materials Science 0.2×
- Economics, Econometrics and Finance 0.1×
- Engineering 0.1×
- Arts and Humanities 0.1×
- Computer Science 0.1×
- Mathematics 0.1×
- Social Sciences 0.1×
- Energy 0.1×
- Physics and Astronomy 0.1×
- Business, Management and Accounting 0.0×
Who are the top researchers at Instituto de Biomedicina de Sevilla?
Ranked on the composite score, Amancio Carnero, Michael J. McConnell and Luis M. Escudero lead among researchers whose main affiliation is Instituto de Biomedicina de Sevilla.
- 1 Amancio Carnero Spain · #213,633 worldwide 187 citations · 43 works
- 2 Michael J. McConnell Spain · #501,699 worldwide 114 citations · 16 works
- 3 Luis M. Escudero Spain · #1,006,205 worldwide 4 citations · 26 works
- 4 Teresa Caballero‐Velázquez Spain · #1,287,161 worldwide 20 citations · 19 works
- 5 Antonio Ordóñez Spain · #1,457,512 worldwide 29 citations · 23 works
- 6 Tarik Smani Spain · #1,571,551 worldwide 27 citations · 16 works
- 7 Alicia Martínez-García Spain · #1,629,191 worldwide 4 citations · 15 works
Which keywords describe research at Instituto de Biomedicina de Sevilla?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Inflammation, Oxidative Stress, Metabolic Syndrome, Cancer, Neurodegeneration, Insulin Resistance and Antibiotic Resistance.
- NASH
- Cancer Immunotherapy
- ESKAPE Pathogens
- Apoptosis
- Cytokines
- Atherosclerosis
- Immunity
- Parkinson's Disease
- Genetic Mutations
- Prognostic Factors
- Neurological Disorders
- Aging
- Chemotherapy
- Depression
- Antibiotic Resistance
- Immunotherapy
- Insulin Resistance
- Cardiovascular Disease
- Cancer
- Inflammation
- Epidemiology
- Oxidative Stress
- Metabolic Syndrome
- Treatment
- Diagnosis
- Neurodegeneration
- Biomarkers
- Immune Response
- Neuroinflammation
- Management
- Antimicrobial Resistance
- Clinical Practice Guidelines
- Global Burden
- Antiretroviral Therapy
- Mitochondrial Dysfunction
- Hepatic Steatosis
- Drug Resistance
- Hepatocellular Carcinoma
- Multidrug-Resistant Bacteria
- NAFLD
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology46▲ 2.7×100 topics
- Inflammation30▲ 3.4×69 topics
- Oxidative Stress27▲ 3.9×52 topics
- Cancer19▲ 3.3×47 topics
- Metabolic Syndrome16▲ 4.8×20 topics
- Cardiovascular Disease14▲ 3.1×30 topics
- Treatment13▲ 2.6×33 topics
- Insulin Resistance13▲ 6.7×9 topics
- Diagnosis13▲ 3.2×31 topics
- Immunotherapy12▲ 3.9×18 topics
- Neurodegeneration12▲ 9.4×11 topics
- Antibiotic Resistance11▲ 6.9×9 topics
- Biomarkers11▲ 3.9×15 topics
- Depression10▲ 2.8×17 topics
- Immune Response10▲ 4.3×18 topics
- Chemotherapy10▲ 3.3×23 topics
- Neuroinflammation10▲ 8.2×6 topics
- Aging10▲ 4.2×15 topics
- Management10▲ 2.9×22 topics
- Neurological Disorders9▲ 3.9×18 topics
- Antimicrobial Resistance9▲ 11×7 topics
- Prognostic Factors9▲ 4.9×12 topics
- Clinical Practice Guidelines9▲ 3.8×14 topics
- Genetic Mutations9▲ 4.7×21 topics
- Global Burden8▲ 3.6×12 topics
- Parkinson's Disease8▲ 7.8×8 topics
- Antiretroviral Therapy8▲ 11×6 topics
- Immunity7▲ 4.3×10 topics
- Mitochondrial Dysfunction7▲ 5.8×12 topics
- Atherosclerosis7▲ 5.9×11 topics
- Hepatic Steatosis7▲ 11×2 topics
- Cytokines7▲ 5.9×8 topics
- Drug Resistance7▲ 5.8×7 topics
- Apoptosis7▲ 5.3×17 topics
- Hepatocellular Carcinoma7▲ 7.6×3 topics
- ESKAPE Pathogens6▲ 26×1 topic
- Multidrug-Resistant Bacteria6▲ 26×1 topic
- Cancer Immunotherapy6▲ 8.7×3 topics
- NAFLD5▲ 11×1 topic
- NASH5▲ 11×1 topic
Which research topics does Instituto de Biomedicina de Sevilla publish most on?
By volume in 2022–2025: Antibiotic Resistance in Bacteria, Liver Disease Diagnosis and Treatment, CAR-T cell therapy research and Antibiotics Pharmacokinetics and Efficacy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antibiotic Resistance in Bacteria Molecular Medicine 6 works
- 2 Liver Disease Diagnosis and Treatment Epidemiology 5 works
- 3 CAR-T cell therapy research Oncology 4 works
- 4 Antibiotics Pharmacokinetics and Efficacy Pharmacology 4 works
- 5 Parkinson's Disease Mechanisms and Treatments Neurology 3 works
- 6 Alzheimer's disease research and treatments Physiology 3 works
- 7 Acute Myeloid Leukemia Research Hematology 3 works
- 8 COVID-19 Clinical Research Studies Infectious Diseases 3 works
- 9 Schizophrenia research and treatment Psychiatry and Mental health 3 works
- 10 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto de Biomedicina de Sevilla's research output changed?
Output in 2018–2022 was 31% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seville
- Universidad de Sevilla
- Universidad Pablo de Olavide
- Hospital Universitario Virgen del Rocío
- Hospital Universitario Virgen Macarena
- Junta de Andalucía
- Estación Biológica de Doñana
- Instituto de la Grasa
- Hospital Universitario de Valme
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.